Tumor-related leukocytosis predictive of recurrence and survival in patients with oral cavity squamous cell carcinoma
Oral Diseases Jun 12, 2019
Roh JL, et al. - Researchers examined whether tumor-related leukocytosis (TRL) is valuable as a predictive biomarker for recurrence and survival after definitive surgery for oral cavity squamous cell carcinoma (OSCC). In this retrospective study of 322 patients who underwent tumor extirpation combined with neck dissection for treatment-naïve OSCC, they noted a significant association of TRL with advanced disease status, tumor size, invasion depth, poor differentiation, and T and N classifications, resulting in enhanced posttreatment recurrence rate, particularly in the distant site.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries